Lead optimized compound was presented in American Association of Cancer Research (AACR) Annual Meeting in Orlando in 2023. Researchers have identified…
New York, NY, May 22, 2023 – A2A Pharmaceuticals, a clinical-stage biopharmaceutical company, announced FDA clearance for their Investigational New Drug…
January 15, 2024 – A2A Pharmaceuticals has announced the dosing of the first patient in their Phase I trial for AO-252,…
New York, NY, September 5th, 2023 – A2A Pharmaceuticals, a company dedicated to discovering and developing novel small molecules for genetically…
Follow us to stay updated on the latest advancements in innovative cancer therapies and OncoCube's progress. Get firsthand access to important information for your health!